S. V. Morant

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

Bryan Williams, Thomas M. MacDonald, S. V. Morant et al. · The Lancet · 2015 · 1.2K citations · Full text

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +16

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Bryan Williams, Thomas M. MacDonald, S. V. Morant et al. · The Lancet Diabetes & Endocrinology · 2018 · 331 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Rates of Production of Acetate, Propionate, and Butyrate in the Rumen of Lactating Dairy Cows Given Normal and Low-Roughage Diets

John Sutton, M.S. Dhanoa, S. V. Morant et al. · Journal of Dairy Science · 2003 · 324 citations · Full text

Agriculture, Animal Sciences, Dairy Science +14

Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database

Isla S. Mackenzie, S. V. Morant, Glenys A. Bloomfield et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 301 citations · Full text

Medicine, Health Sciences, Neurology +7

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

Thomas M. MacDonald, S. V. Morant, Geoffrey C. Robinson et al. · BMJ · 1997 · 297 citations

Medicine, Pharmacology, Pharmacotherapy +14